Fibrosis associated with dopamine agonist therapy in Parkinson's disease

Clin Neuropharmacol. 2003 May-Jun;26(3):109-11. doi: 10.1097/00002826-200305000-00001.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Fibrosis / chemically induced*
  • Humans
  • MEDLINE
  • Parkinson Disease / drug therapy*
  • Risk Factors

Substances

  • Dopamine Agonists